Skip to content
healthcare.dev

Lacosamide

NDC 62332-173, lacosamide, tablet, film coated, from Alembic Pharmaceuticals Inc..

Product NDC
62332-173
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204974
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-173 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE150 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
62332-173-1062332017310100 BLISTER PACK in 1 CARTON (62332-173-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
62332-173-306233201733030 TABLET, FILM COATED in 1 BOTTLE (62332-173-30)
62332-173-606233201736060 TABLET, FILM COATED in 1 BOTTLE (62332-173-60)
62332-173-91623320173911000 TABLET, FILM COATED in 1 BOTTLE (62332-173-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/07b7b3f2-16a0-4deb-883b-10522676d966
  • NADAC price for package 62332017360

    GET /v1/drugs/nadac/62332017360

Use it

Look up 62332-173 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-173 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.